China is becoming an increasingly key player in the global healthcare landscape. At HBI 2026, a panel explored the opportunities emerging in China and what it means for innovation, knowledge sharing, and trade flows between Europe and China.
Private equity firm Nord Holding has acquired a majority stake in the VisionmaxX Group, a German healthcare IT service provider. VisionmaxX provides IT services, including IT infrastructure, telematics, IT security, and digital practice solutions for German and Austrian dental practices, orthodontists, and oral and maxillofacial surgeons.
HBI spoke with Charles Bourgain, Executive Director at Extens, about the firm’s sector-focused investment strategy and the growing role of AI in healthcare IT.
This week we have published our third annual Special Report on European healthcare property investment. As well as an update on the general state of investment activity in the market, this report features more case studies than last year’s report, and an even more in-depth discussion on the on-going dearth of new developments across most of the continent, and what investors and operators can do to ameliorate the situation.
At HBI 2026, a panel featuring Andrej Babache, Managing Director, Direct Private Equity at investment firm CPP Investments, Chenyang Xu, President and Co-Chairman at medical technology company PVmed, and James Levine, President at Foundation IPSEN, a non-profit dedicated to medical research and science communication, explored how healthcare value could be reshaped by 2030.
Pan-European diagnostics and outpatient group Affidea is selling all of its Hungarian operations to Medicare Group, a Hungary-based private healthcare provider, marking a full exit from the country where it was founded in 1991.
Polypeptide Group, a contract development and manufacturing organisation (CDMO) serving pharmaceutical and biotech companies, has attracted takeover interest from private equity investors. The company specialises in peptide-based active pharmaceutical ingredients (APIs) and operates manufacturing sites across the United States, Europe, and India.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.